Long-term safety and efficacy of elagolix treatment in women with endometriosis-associated pain: primary results from two phase 3 extension studies

Eric S. Surrey, Hugh S. Taylor, L.C. Giudice, S. S. Singh, Maurício Simões Abrão, Bruce A. Lessey, W. Rachel Duan, Paul M. Peloso, Brittany Schwefel, Kristof Chwalisż
In: Fertility and Sterility · 2017 · vol. 108(3) , pp. e95–e96 · doi:10.1016/j.fertnstert.2017.07.293 · W2751463235
OA: closed CC0 ⤵ 2 in-corpus citations
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Two Phase 3 extension studies evaluated the long-term safety and efficacy of elagolix for women with endometriosis-associated pain, reporting primary outcomes of this extended treatment period.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-11-07T06:39:01.373405+00:00
License: CC0 · commercial use OK